Trials / Completed
CompletedNCT07257666
Sensory Deficit Following ACL Reconstruction: PRF Pilot Study
The Effect of Platelet-rich Fibrin on the Regeneration of Patellar Ligament Defects and the Functional Recovery of Patients After Anterior Cruciate Ligament Reconstruction of the Knee
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (actual)
- Sponsor
- University of Belgrade · Academic / Other
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
Pilot, single-center, non-randomized, parallel-group clinical study designed to assess whether intraoperative application of autologous platelet-rich fibrin (PRF) at the bone-patellar tendon-bone (BPTB) donor site reduces postoperative anterior knee sensory deficit after anterior cruciate ligament (ACL) reconstruction in competitively active male athletes. Planned enrollment is 53 participants allocated to a PRF cohort or a standard-care cohort. The primary outcome is the proportion of participants without anterior knee sensory deficit at 12 months post-surgery.
Detailed description
Background: Sensory deficit around the BPTB donor site is a recognized complication after ACL reconstruction and may affect patient satisfaction and functional recovery. PRF is an autologous bioregenerative product with potential to support soft-tissue healing. Objective: To determine whether PRF application at the donor site reduces anterior knee sensory deficit compared with standard surgical care. Design and Participants: Single-center, prospective, pilot, non-randomized study with two parallel cohorts (PRF vs standard care). Competitively active male athletes meeting prespecified eligibility criteria are followed at 4, 8, and 12 months post-surgery. Recruitment window: January 2022 to January 2023. Interventions: In the PRF cohort, PRF is prepared intraoperatively and applied to the donor site per manufacturer protocol; the comparator cohort receives standard closure without PRF. Assessments: Primary outcome: Proportion of participants without anterior knee sensory deficit at 12 months. Sensory testing is performed over a predefined 9-point area lateral to the surgical scar (eyes closed; contralateral knee used as reference if uncertain). Secondary outcomes: Patient-reported knee function instruments (International Knee Documentation Committee \[IKDC\] Subjective Knee Form and Lysholm Knee Scoring Scale), each reported as total score (0-100; higher scores indicate better function) at 4, 8, and 12 months; optional MRI-based assessments of the donor site per protocol; safety monitoring of adverse events. Analysis (planned): Group comparisons using appropriate categorical and non-parametric methods with prespecified approaches to handle multiplicity.
Conditions
- Anterior Cruciate Ligament Injury
- Knee Injuries
- Sensory Disorders
- Bone-Patellar Tendon-Bone Autograft
- Platelet-Rich Fibrin (PRF)
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Platelet-rich fibrin (PRF) | Autologous PRF prepared intraoperatively from patient's venous blood and applied at the donor site after graft harvesting. |
| PROCEDURE | Standard Closure (Control) | Conventional closure of the donor site without PRF application |
Timeline
- Start date
- 2022-01-07
- Primary completion
- 2023-01-07
- Completion
- 2025-07-14
- First posted
- 2025-12-02
- Last updated
- 2025-12-15
Locations
1 site across 1 country: Serbia
Source: ClinicalTrials.gov record NCT07257666. Inclusion in this directory is not an endorsement.